Home » Analyst Articles – US
Prime Medicine (NYSE:PRME) Stock Rating Upgraded by StockNews.com
StockNews.com upgraded shares of Prime Medicine (NYSE:PRME – Free Report) to a sell rating in a research note released on Tuesday. Other equities research analysts also recently issued research reports about the stock. HC Wainwright... More of this article »
Agilent Technologies (NYSE:A) Upgraded to “Buy” at StockNews.com
StockNews.com upgraded shares of Agilent Technologies (NYSE:A – Free Report) from a hold rating to a buy rating in a report issued on Tuesday morning. Other equities research analysts also recently issued research reports about... More of this article »
Avangrid (NYSE:AGR) Coverage Initiated by Analysts at StockNews.com
StockNews.com started coverage on shares of Avangrid (NYSE:AGR – Free Report) in a report released on Tuesday morning. The firm issued a hold rating on the utilities provider’s stock. Avangrid Price Performance Avangrid... More of this article »
China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a research report released on Tuesday morning. The firm issued a hold rating on the stock. China Pharma Stock Performance Shares of China Pharma... More of this article »
IDT (NYSE:IDT) Stock Rating Lowered by StockNews.com
StockNews.com cut shares of IDT (NYSE:IDT – Free Report) from a strong-buy rating to a buy rating in a research report released on Tuesday. IDT Stock Performance Shares of IDT stock opened at $47.68 on Tuesday. IDT has a 52 week... More of this article »
Roth Mkm Has Lowered Expectations for MGP Ingredients (NASDAQ:MGPI) Stock Price
MGP Ingredients (NASDAQ:MGPI – Get Free Report) had its price target cut by Roth Mkm from $65.00 to $60.00 in a report released on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Roth... More of this article »
Anavex Life Sciences (NASDAQ:AVXL) Receives “Buy” Rating from D. Boral Capital
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at D. Boral Capital in a research report issued on Monday,Benzinga reports. They currently... More of this article »
Navient (NASDAQ:NAVI) Given New $16.00 Price Target at Bank of America
Navient (NASDAQ:NAVI – Free Report) had its target price trimmed by Bank of America from $17.00 to $16.00 in a research report released on Tuesday,Benzinga reports. The brokerage currently has a neutral rating on the credit services... More of this article »